Vaccine Harms Are Biodefense Plan’s Collateral Damage

Vaccine Harms Are Biodefense Plan’s Collateral Damage
dizain/Shutterstock
Debbie Lerman
Updated:
0:00
Commentary
Recently, revelations by outstanding artist and writer/researcher/investigator Sasha Latypova about COVID genetic vaccines have shed light on the shady, and as she calls it criminal, process by which the vaccine products were manufactured and authorized.

Medical Countermeasures With No Regulatory Oversight

Latypova combed through FOIA-extracted and leaked documents to find convincing evidence that COVID vaccine manufacture and distribution were conducted by the U.S. Department of Defense (DoD) under laws covering “medical countermeasures,” rather than regulations intended to ensure the safety of pharmaceutical products. Consequently, the COVID vaccines could bypass regulatory scrutiny and were not required to comply with good manufacturing practices.
Debbie Lerman
Debbie Lerman
Author
Debbie Lerman has a degree in English from Harvard. She is a retired science writer and a practicing artist in Philadelphia, Pennsylvania.
Related Topics